Trials / Sponsors / KBP Biosciences

KBP Biosciences

Industry · 13 registered clinical trials.

Status	Trial	Phase	Started
Completed	Study of KBP-7072 in Healthy Male and Female Subjects Healthy Subjects	Phase 1	2022-08-16
Terminated	Efficacy and Safety of KBP-5074 in Uncontrolled Hypertension and Moderate or Severe Chronic Kidney Disease (CK Chronic Kidney Diseases	Phase 3	2021-11-05
Completed	Mass Balance Study of KBP-5074 in Healthy Male Subjects Healthy	Phase 1	2020-12-03
Completed	Drug to Drug Interaction Study of KBP-5074 in Healthy Subjects Healthy, Drug Drug Interaction	Phase 1	2020-10-24
Completed	Pharmacokinetics of KBP-5074 in Patients With Moderate Hepatic Impairment Moderate Hepatic Impairment, Healthy	Phase 1	2020-08-27
Completed	A Multiple Ascending Dose Study to Investigate Safety of KBP-7072 in Healthy Subjects Healthy	Phase 1	2020-08-11
Completed	Phase 2b Study of KBP-5074 in Subjects With Uncontrolled Hypertension and Advanced Chronic Kidney Disease Chronic Kidney Diseases, Hypertension	Phase 2	2018-04-25
Completed	Bioavailability of KBP-5074 Tablet vs Capsule Formulations Bioequivalence	Phase 1	2017-10-26
Completed	Safety, Tolerability, and Pharmacokinetics of KBP-5074 Following Oral Administration in Chronic Kidney Disease Chronic Kidney Disease	Phase 1	2016-07-13
Completed	A Multiple Ascending Dose Study of KBP-7072 in Healthy Subjects Healthy	Phase 1	2015-10-01
Completed	Safety, Tolerability and Pharmacokinetics of KBP-5074 in Healthy Subjects and Subjects With Renal Impairment Healthy, Renal Insufficiency	Phase 1	2015-07-29
Completed	Safety, Tolerability and Pharmacokinetics of KBP-7072 Healthy	Phase 1	2015-05-01
Completed	Phase 1 Single Ascending Dose Study to Evaluate Safety, Tolerability and Pharmacokinetics of KBP-5074 Healthy	Phase 1	2014-06-01